Skip to main content
Clinical Trials/NCT07257159
NCT07257159
Completed
Not Applicable

End-of-Life Care Preparedness Program for Senior Nursing Students: Effects on Attitudes and Self-Efficacy in a Randomized Controlled Trial

Hilal ALTUNDAL DURU1 site in 1 country59 target enrollmentStarted: April 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Hilal ALTUNDAL DURU
Enrollment
59
Locations
1
Primary Endpoint
End-of-Life and Postmortem Self-Efficacy Scale (ELPSES)

Overview

Brief Summary

In this study, between 1 April- 31 May 2025, who met the inclusion and exclusion criteria, a total of 59 senior nursing students who are with 4th year nursing students starting the Nursing Department of Çankırı Karatekin University and Sakarya Applied Sciences University.

Detailed Description

The End-of-Life Care Preparedness Program will be held in a online environment for the students in the intervention group. This training program has been developed based on the literature. The primary aim of the program was to enable participants to recognize their own thoughts and emotions about death, and to support their development in key areas of end-of-life care. Specifically, the content addressed providing care to dying individuals, caring for the deceased person, preparing the body after death, and offering psychosocial support to the bereaved family. The intervention consisted of four weekly sessions, each lasting approximately 90 minutes, delivered in an online group format via online. The training program will be applied to 29 senior nursing students in the intervention group. The sessions were structured to include psychoeducational content, interactive exercises, group discussions, and opportunities for reflection.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Masking Description

Senior nursing students in the intervention and control groups will be masked.

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • final-year nursing students
  • consent to take part voluntarily
  • accessed to the required technology and competencies for attending online sessions

Exclusion Criteria

  • failed to complete the data collection tools in full
  • missed intervention sessions
  • chosed to withdraw at any point during the intervention or follow-up phase

Outcomes

Primary Outcomes

End-of-Life and Postmortem Self-Efficacy Scale (ELPSES)

Time Frame: Change from before education (Time 0) and after education (four weeks-Time 1) up to after the at the end of the education one month later (Time 2).

This instrument was evaluate nursing students' self-efficacy regarding end-of-life and postmortem care. The scale consists of 18 items and is formatted as a visual analog scale. For each item, participants indicate their perceived level of self-efficacy on a continuum from 0 (not confident at all) to 100 (extremely confident) using a slider mechanism. The overall self-efficacy score is calculated by averaging responses across items. In the original development study, the Cronbach's alpha for the scale was reported as 0.93.

Frommelt Attitudes Toward Care of the Dying Scale (FATCOD)

Time Frame: Change from before education (Time 0) and after education (four weeks-Time 1) up to after the at the end of the education one month later (Time 2).

The FATCOD, originally developed by Frommelt (1991), was used to assess participants' attitudes toward caring for dying patients. The Turkish adaptation and validation of the scale was conducted by Çevik and Kav (2013). The scale contains 30 items rated on a 5-point Likert scale and includes both positively and negatively worded statements. Negative items are reverse-coded before computing the total score, which ranges from 30 to 150, with higher scores indicating more positive attitudes toward caring for dying patients. In the Turkish validation study, the Cronbach's alpha reliability coefficient was reported as 0.73.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Hilal ALTUNDAL DURU
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Hilal ALTUNDAL DURU

Doctor

Mersin University

Study Sites (1)

Loading locations...

Similar Trials